About this trial
The first aim of this project is to investigate the effects of different high-tech neurorehabilitation interventions (cognitive, motor, and combined cognitive-motor) on both cognitive and motor disability outcomes in people with multiple sclerosis (MS).
The second aim is to identify the cognitive and motor profiles of MS patients who benefit the most from either the combined cognitive-motor rehabilitation intervention or the isolated cognitive or motor treatments.
Eligibility criteria
Qualifiers
presence of mild (one or two neuropsychological tests below the cut-off score, 5th percentile) or severe (more than two neuropsychological tests below the cut-off score, 5th percentile) cognitive impairment,
mild to moderate walking disability with Expanded Disability Status Scale (EDSS) between 3 and 6,
no relapse or associated steroid use in the past three months,
adequate visual and auditory capacity to operate computer software.
Disqualifiers
presence of other neurological disorders than MS,
major psychiatric disorders,
high levels of anxiety and/or depression (score>20 for Depression scale and up to 14 for Anxiety scale on Italian adaptation of the Depression, Anxiety and Stress Scale (DASS-21),
substance abuse,
Trial design
Treatments tested in this trial
- Cognitive rehabilitation: CG group
- Motor rehabilitation: MG group
- Combined rehabilitation: CbG group